Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants

NCT06208540 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Post-covid-19 Persistent Smell and Taste Disorders

Interventions

DRUG: Cerebrolysin
OTHER: olfactory and gustatory trainings

Sponsor

Sherifa Ahmed Hamed